Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Namilumab by Izana Bioscience for Ankylosing Spondylitis (Bekhterev's Disease): Likelihood of Approval
Namilumab is under clinical development by Izana Bioscience and currently in Phase II for Ankylosing Spondylitis (Bekhterev's Disease). According to...
Data Insights
Namilumab by Izana Bioscience for Axial Spondyloarthritis: Likelihood of Approval
Namilumab is under clinical development by Izana Bioscience and currently in Phase II for Axial Spondyloarthritis. According to GlobalData, Phase...